The p53-transcriptional target, BTG2 TIS21/PC3 , was previously identified as an antiproliferative gene. However, the precise biological functions of the protein product remain to be elucidated. BTG2 TIS21/PC3 expression is induced in vivo during neurogenesis, and the gene is transiently expressed in vitro in rat pheochromocytoma PC12 cells after induction of neuronal differentiation by addition of nerve growth factor (NGF). These observations suggest that BTG2 TIS21/PC3 is functionally significant during the neuronal differentiation process. To test this hypothesis, a vector that expressed BTG2 TIS21/PC3 under the control of an inducible promoter was introduced into PC12 cells. Growth arrest and differentiation in response to NGF were greatly enhanced by BTG2 TIS21/PC3 overexpression. Furthermore, an antisense oligonucleotide complementary to BTG2 TIS21/PC3 mRNA, which was able to inhibit endogenous BTG2 TIS21/PC3 expression, triggered programmed cell death in differentiated PC12 cells. These observations confirm that BTG2 TIS21/PC3 expression promotes neuronal differentiation and that it is required for survival of terminally differentiated cells.
Introduction
The human BTG2 TIS21/PC3 gene is a member of a newly identified family of six independent antiproliferative genes, namely, BTG1, ANA/BTG3, PC3B, TOB, TOB2 (Rouault et al., 1992; Matsuda et al., 1996; Guehenneux et al., 1997; Yoshida et al., 1998; Ikematsu et al., 1999; Buanne et al., 2000; Tirone, 2001) . Although the biological functions of the BTG2 TIS21/PC3 protein remain to be elucidated, several studies have attempted to identify the different cues capable of inducing its expression. We previously reported that BTG2 TIS21/PC3 expression is enhanced in response to genotoxic stress through a p53-dependent mechanism (Rouault et al., 1996; Cortes et al., 2000) . BTG2 TIS21/PC3 is also transiently expressed in response to signals such as epidermal growth factor (EGF), tumor promoter agent (TPA), or the addition of serum to starved cells (Bradbury et al., 1991; Fletcher et al., 1991) . However, several in vivo and in vitro observations suggest that it may play a role in neuronal differentiation. In vivo, BTG2 TIS21/PC3 is considered as a marker of neuronal birth (Iacopetti et al., 1994) . Indeed, the BTG2 TIS21/PC3 gene is specifically expressed in neuroepithelial cells that will generate postmitotic neurons (Iacopetti et al., 1999) . Its overexpression affects the pattern of cell division of cortical precursors in rats (Malatesta et al., 2000) . In vitro, BTG2 TIS21/PC3 is activated by NGF at the onset of neuronal differentiation in PC12, a cell line derived from a murine adrenal medulla tumor (Bradbury et al., 1991) . In the PC12nn25 mutant cell line, characterized by a defect in NGF receptormediated endocytosis, BTG2 TIS21/PC3 response to NGF is completely abolished and cells remain undifferentiated (Altin et al., 1991) . Interestingly, the BTG2 TIS21/PC3 protein physically interacts with and activates the PRMT1 protein-arginine-N-methyltransferase (Lin et al., 1996) whose function is required for PC12 differentiation by NGF (Cimato et al., 1997 expression and as a control PC12-2 clone, which displayed no expression of BTG2 TIS21/PC3 , even after IPTG addition. As shown on Figure 2a , the expression of exogenous BTG2 TIS21/PC3 mRNA was increased in PC12-18 and PC12-27 cells following exposure to IPTG for 12 h. BTG2 TIS21/PC3 protein levels also increased after IPTG addition, with a kinetic profile similar to that of exogenous BTG2 TIS21/PC3 mRNA ( Figure 2b ). Maximum expression levels were reached within 3 days of IPTG exposure. In PC12 sublines, the ectopic expression persisted up to 8 days following IPTG addition, then lasted 6 days after IPTG was removed from the medium (results not shown).
Growth of PC12 cells containing an inducible
The proliferative status of PC12-18 and PC12-27 cells cultured in the absence and in the presence of IPTG was investigated. Similar data were obtained for both clones. As shown on Figure 2c , IPTG-induced BTG2 TIS21/PC3 expression caused a significant decrease in cell growth whereas neither cell viability nor cell morphogenesis were significantly affected (data not ). Transfected BTG2 TIS21/PC3 lacks approximately 1400 base pairs of the 3'untranslated region contained in endogenous BTG2 TIS21/PC3 . 18S ribosomal RNA is shown to demonstrate equal loading of total RNA TIS21/PC3 induction was studied in PC12-27 cell line, either untreated (green box), or following exposure to 3 mM IPTG (pink box). Quantification was performed by counting the cell number at a given time. Data are expressed as means (+stan-dard deviation)
shown). Cell cycle progression was then analysed using flow cytometry to measure changes in the DNA content. BTG2 TIS21/PC3 overexpression in PC12-27 cells caused partial growth inhibition within 1 day of IPTG exposure, with a slight decrease in the number of cells in S phase (8 versus 13% in control cells) and a slight increase in the number of cells in G1 (63 and 58% in induced and control cells, respectively).
Effects of BTG2 TIS21/PC3 expression on PC12 differentiation
It is known that BTG2 TIS21/PC3 is expressed in PC12 cells after induction of neuronal differentiation by NGF. In order to demonstrate the role of BTG2 TIS21/PC3 in NGF-induced differentiation, PC12-18 and PC12-27 lines were treated, either with NGF alone or with a combination of IPTG and NGF (100 ng/ml). Neuronal differentiation was estimated by neurite outgrowth which was correlated with enhanced levels of the neuron-specific marker of differentiation aenolase (data not shown) (Vinores et al., 1981; Marz et al., 1997) . After NGF treatment 20% of PC12-18 and PC12-27 lines developed neurites, whereas after IPTG/NGF treatment, up to 80% of cells differentiated (Figure 3a ,b). These data suggested that induction of BTG2 TIS21/PC3 expression, substantially enhanced responsiveness to NGF-induced neurite outgrowth suggesting that these cells differentiated more rapidly in the presence of BTG2 TIS21/PC3 .
BTG2
TIS21/PC3 is involved in the survival of NGF treated PC12
To confirm the role of BTG2 TIS21/PC3 in the differentiation process, differentiation of NGF-treated PC12 cells was triggered in the presence of an antisense phosphorothioate oligodeoxynucleotide designed to interfere with BTG2 TIS21/PC3 expression. After treatment with antisense oligonucleotide AS-BTG2, the expression of the BTG2 TIS21/PC3 protein was reduced to levels lower than the basal level seen in untreated cells, as judged by Western blot analysis (Figure 4a ). Conversely, BTG2 TIS21/PC3 protein levels were unaffected by treatment with a non specific oligonucleotide (Figure 4a ). In the absence of NGF treatment, AS-BTG2 had no effect on PC12 cells (Figure 4c) . However, the addition of NGF to PC12 cells treated by AS-BTG2 triggered a massive cell death, as evidenced by an increased number of floating cells. The percentage of apoptotic cells was then evaluated by the TUNEL method: 20% of apoptotic cells were observed 6 days after treatment with AS-BTG2, compared to 4% after treatment with a control non specific oligonucleotide (Figure 4b,c) . This increase in apoptotic cell death was confirmed by cell-cycle analysis evidencing the emergence of a significant sub-G1 cell population (data not shown). Taken together these data strongly suggest that BTG2 TIS21/PC3 is required for the survival of NGF treated PC12 cells.
Discussion
To understand the different aspects of neuronal differentiation, the PC12 rat pheochromocytoma cell line has frequently been used as an in vitro model. Undifferentiated PC12 cells proliferate in the presence of serum; however, the addition of NGF results in a sympathetic-like neuronal differentiation, including complete mitotic arrest (Rudkin et al., 1989; van Grunsven et al., 1996) . The present study demonstrates that the forced expression of the antiproliferative BTG2 TIS21/PC3 gene enhances NGF-induced neuronal differentiation and favors the survival of differentiated PC12 cells. Cell-cycle arrest is known to be an essential preliminary requirement for terminal differentiation. Other studies have shown that proliferation inhibitors combined with NGF treatment, enhance the differentiation rate of PC12 cells (Gupta et al., 1987) . Similar findings resulted from culturing PC12 cells in serum-free medium prior to NGF addition (Rudkin et al., 1989) . However, the in vivo mechanisms governing this process are not completely understood. Much attention has focused on the regulation of components known to control progression through cell cycle, including cyclins, cyclin-dependent kinases and cyclindependent kinase inhibitors (Erhardt and Pittman, 1998) . In addition to previous reports, our data show that BTG2 TIS21/PC3 expression may play a significant role on the control of cell growth. In vitro, BTG2 TIS21/PC3 was known to trigger a G1 arrest in pheochromocytoma PC12 cells and in non-neuronal cells (Montagnoli et al., 1996; Guardavaccaro et al., 2000) . However, the inducible overexpression of BTG2 TIS21/PC3 led only to a partial G1-arrest in the absence of NGF (Figure 2 ), suggesting that its induction was not sufficient to trigger the G1 block that characterizes neuronal differentiation by NGF. In vivo, BTG2 TIS21/PC3 expression was observed during neurogenesis, in the subset of neuroblasts differentiating into post-mitotic neurons (Iacopetti et al., 1999) . The expression of the protein was sustained during the mitosis of neuron-generating neuroepithelial cells, and during a few days in post-mitotic neuronal daughter cells. This observation is consistent with the hypothesis that BTG2 TIS21/PC3 induction does not trigger a complete cell-cycle arrest, but more probably reduces the cycling rate of neuroepithelial cells to below a certain threshold, thereby forcing the cells to switch from a proliferative symmetric mode (that generates two proliferating daughter neuroepithelial cells) to asymmetric division (that gives one post-mitotic neuron and one neuroepithelial cell) (Tirone, 2001; Malatesta et al., 2000) . This function may be common to other members of the BTG/TOB family. Like BTG2 TIS21/PC3 , BTG3/ANA is expressed in the neuroepithelial cells of the ventricular zone of the developing central nervous system (Yoshida et al., 1998) . BTG2 TIS21/PC3 and BTG3/ANA may thus have overlapping roles in the growth arrest of neural precursor cells at the time when the commitment of the precursor cells to the neural or glial lineage occurs.
BTG2 TIS21/PC3 triggers differentiation of PC12 cells F el-Ghissassi et al
Apart from the role of BTG2 TIS21/PC3 as a signal transducer at the onset of neurogenesis, data of experiments using antisense phosphorothioate oligodeoxynucleotide suggest that BTG2 TIS21/PC3 expression is required for the survival of post-mitotic neuronal daughter cells. This observation is highly reminiscent of the apoptotic cell death of differentiated PC12 cells after NGF withdrawal (Greene, 1978) . Similarly, the inhibition of BTG2 TIS21/PC3 expression may trigger programmed cell death as a consequence of terminally differentiated cells attempting to re-enter the cycle. Consistent with this role of BTG2 TIS21/PC3 as a survival factor in NGF treated cells, our team previously showed that the differentiated embryonic stem cells from which BTG2 TIS21/PC3 had been ablated underwent apoptosis following DNA damage because of a failure in growth arrest (Rouault et al., 1996) .
Another key event in the growth arrest associated with the differentiation process is the induction of the p21 Waf1 cyclin-dependent kinase inhibitor. p21 Waf1 is upregulated during the NGF-induced cell cycle block in PC12 cells. The experimental overexpression of p21
Waf1 is sufficient to induce differentiation-specific cell cycle events (Erhardt and Pittman, 1998) . Interest- TIS21/PC3 and p21 Waf1 are known to be transcriptional targets of the tumor suppressor p53, in response to DNA damage (Rouault et al., 1996; elDeiry et al., 1993) . In contrast to p53, the p53-homolog p73 plays a critical role in neuronal differentiation. P73-deficient mice show major neurological defects (Yang et al., 2000) . In vitro, endogenous p73 levels increase in neuroblastoma cells induced to differentiate by retinoic acid. The experimental overexpression of p73 (but not p53) is sufficient to induce both morphological (neurite outgrowth) and biochemical markers of neuronal differentiation (de Laurenzi et al.,
2000). p21
Waf1 and BTG2 TIS21/PC3 are transcriptionally induced by p73 (Zhu et al., 1998) , their expression increases during the differentiation of neuroblastoma cells (unpublished data). Studies are ongoing to assess whether p21
Waf1 and BTG2 TIS21/PC3 act as p73 downstream targets in this process.
While this manuscript was under review, we learned that another, independent study reported that transient transfection of BTG2 TIS21/PC3 was able to potentiate the effect of NGF on differentiation (Corrente et al., 2002) . Combined data clearly demonstrate the role of BTG2 TIS21/PC3 in neuronal differentiation.
Materials and methods
Cell culture PC12 cells were grown at 378C (5% CO 2 ) in DMEM (4.5 g/l glucose) with 6% donor heat-inactivated horse serum, 6% heat-inactivated fetal bovine serum, 10 mM HEPES, 10 mM glutamine, 100 units/ml penicillin and 100 mg/ml streptomycin. Cells were cultured in plastic tissue culture dishes pre-coated with rat-tail collagen (0.25 mg/ml) (Sigma) and poly-L-lysine (10 mg/ml) (Sigma). Growth medium was supplemented with 200 mg/ml hygromycin B (Gibco-BRL) and 300 mg/ml G418 (Gibco-BRL) in cell lines transfected with Lac repressor and BTG2
TIS21/PC3
expression plasmids. For induction of BTG2 TIS21/PC3 in transfected lines, 3 mM IPTG (Boehringer Mannheim Biochemicals) were added to the medium. To induce differentiation, 100 ng/ml of nerve growth factor (NGF) (Sigma) were added to the same medium as above.
Plasmids
For induction of BTG2 TIS21/PC3 expression, plasmids from the Lac expression kit (Stratagene) were employed. Briefly, this system involves the constitutive expression of the Lac repressor protein and the introduction of a gene of interest (BTG2 TIS21/PC3 ) under the control of a RSV promoter containing Lac repressor protein binding sites. Under normal conditions, the Lac repressor protein binds to Lac operator sites in the RSV promoter, thus inhibiting transcription. For induction of BTG2
TIS21/PC3
, isopropyl-b-D-thiogalactoside (IPTG) was added to the cells. IPTG binds to the Lac repressor protein, thus inhibiting interactions with DNA. The RSV promoter then initiates transcription, leading to ectopic BTG2 TIS21/PC3 expression. The first plasmid, pCMV, contains the Lac repressor protein coding sequence and the hygromicin B resistance gene. The second plasmid, pOPRSV1, is an inducible expression plasmid bearing geneticin G418 resistance, in which a 1.1 kilobase human BTG2 TIS21/PC3 cDNA fragment has been subcloned into the KpnI site. Both plasmids were cotransfected with lipofectin (Gibco-BRL) into PC12 cells according to the manufacturer's instructions. The selection for the clonal expression of both the Lac repressor protein and the BTG2 TIS21/PC3 construct was obtained by addition of hygromicin (200 mg/ml) (Gibco-BRL) and geneticin G418 (300 mg/ml) (Gibco-BRL). Lac repressor protein expression was tested by Western blot analysis and the expression inducible in clones was confirmed with Northern blot and Western blot analyses.
Cell proliferation assay
Cell growth was determined by the measurement of cell numbers after incubation with Trypan blue (0.06% in PBS). 
RNA isolation and Northern blot analysis
Total RNA from PC12 cells was isolated using the tri-reagent method (Sigma). RNA samples (10 mg) were electrophoresed on denaturating formaldehyde agarose gel, then transferred to nylon membranes (Hybond-N+; Amersham). Membranes were hybridized with a a-32 P-dCTP-labeled BTG2 TIS21/PC3
cDNA probe. Bands were visualized by autoradiography.
Protein isolation and Western blot analysis
Cells were lysed on ice in RIPA buffer (50 mM Tris-HCl, 0.1% SDS, 2 mM DTT, 0.5% NP40) containing 1 mM PMSF, 40 mg/ml leupeptin, 40 mg/ml aprotinin, 20 mg/ml pepstatin A. Total protein concentrations were determined by the Bio-Rad protein assay. Aliquots of each sample containing equal amounts of proteins were subjected to Western immunoblot analysis. Briefly, proteins were separated by electrophoresis on a 10% polyacrylamide gel, then transferred to Immobilon polyvinylidene difluoride transfer membrane (Millipore).
Immunological studies
For detection by Western blot, equal amounts of proteins were mixed with Laemmli sample buffer, resolved on 12% SDS-polyacrylamide gel, then transferred onto PVDF membranes (Millipore). Western blot analysis was performed using enhanced chemiluminescence in accordance with the manufacturer's instructions. Specific antibodies to the BTG2 TIS21/PC3 protein were generated by immunizing rabbits with six times His-tagged BTG2 TIS21/PC3 protein, followed by affinity purification involving adsorption to, and elution from a column of BTG2 protein and by negative adsorption to a column of BTG1 protein (Walden et al., 1998) . For the detection of Neuron Specific aEnolase, the primary antibody was Enolase C-19 (Santa Cruz). Peroxidase-conjugated antirabbit or anti-goat IgG (Dako) were used as secondary antibodies.
Cell cycle analysis using flow cytometry (FACS)
Cells were harvested at various times after the different treatments, then fixed with 70% ethanol for at least 20 min.
After centrifugation, the cell pellets were washed twice with PBS, then treated with 100 mg/ml DNase-free RNase A in PBS for 30 min. The nuclei were then stained with propidium iodide used at the concentration of 50 mg/ml. The DNA content of the stained nuclei was measured on a FACScalibur flow cytometer. The Cell Quest software (Becton Dickinson, USA) was used to determine cell cycle phase distribution.
Antisense oligonucleotides
Phosphorothioate oligonucleotides (100 mM) and lipofectin (1 mg/ml) (Gibco) were incubated for 15 min at 378C. The oligonucleotide-lipofectin mixture was diluted with serumcontaining medium, then added to the cells. In most cases, the dilution was 1 : 100, yielding a final oligonucleotideconcentration of 1 mM. Fresh oligonucleotide-containing medium was added to the cells each day. We used 22-mer antisense oligonucleotides complementary to the region of the BTG2 TIS21/PC3 mRNA that encompasses the initiation codon. The oligonucleotides were purchased from GENSET (France). A non specific phosphorothioate 22-mer oligonucleotide (NSO) was used as control.
Detection of apoptotic cell death
The detection of apoptotic cell death was performed using the fluorescein-based in situ cell detection Kit (Enzo Roche). The assay was based upon the detection of DNA degradation using TUNEL (terminal dUTP-fluorescein nick end labeling) staining. The TUNEL assay was conducted on cytospin preparations of cells removed from dishes by trituration in the culture medium (to avoid loss of detached cells) as per manufacturer's instructions. Apoptotic cells were visualized under a Zeiss axioplot 2 fluorescence microscope. The extent of apoptosis was expressed as the ratio of cells that showed positive TUNEL staining on the total number of cells (the total number of cells was calculated from cells stained with Hoechst 33342 (10 mg/ml)). Typically, at least 300 cells per treatment were counted in random fields. Three independent experiments were performed in each study.
